Genetic deletion or pharmacological blockade of IL-1R1 increases renal NO production, reduces NKCC2 function, enhances natriuresis, and protects against hypertension and cardiac hypertrophy. This evidence concerns the gene SLC12A1 and hypertensive disorder.